pyrrolidine dithiocarbamate has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-El-Fattah, MA; Abdelakader, NF; Zaki, HF | 1 |
| Culver, B; Driscoll, MJ; Luhrs, KJ; Malik, WT; Ryff, KA; Zhang, X | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Alzheimer Disease
| Article | Year |
|---|---|
Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Dopamine; Glutathione; Hippocampus; Interleukin-10; Interleukin-1beta; Male; Neuroprotective Agents; Norepinephrine; Pyrrolidines; Rats; Rats, Wistar; Scopolamine; Serotonin; Thiocarbamates | 2014 |
Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Cerebral Cortex; Cyclooxygenase 2; Hippocampus; Injections, Intraperitoneal; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Mutation; NF-kappa B; Protein Precursors; Pyrrolidines; Thiocarbamates; Tumor Necrosis Factor-alpha | 2009 |